|
MRPS10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.907800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.215100E-04 |
| Normal-vs-Stage2 |
4.782400E-01 |
| Normal-vs-Stage3 |
3.452200E-01 |
| Normal-vs-Stage4 |
8.641000E-01 |
| Stage1-vs-Stage2 |
2.796400E-01 |
| Stage1-vs-Stage3 |
1.189400E-01 |
| Stage1-vs-Stage4 |
1.158760E-01 |
| Stage2-vs-Stage3 |
8.968200E-01 |
| Stage2-vs-Stage4 |
4.667400E-01 |
| Stage3-vs-Stage4 |
3.431600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.159800E-01 |
| Normal-vs-AfricanAmerican |
9.007000E-01 |
| Normal-vs-Asian |
7.941400E-01 |
| Caucasian-vs-AfricanAmerican |
7.879000E-01 |
| Caucasian-vs-Asian |
7.700600E-01 |
| AfricanAmerican-vs-Asian |
8.256400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.110600E-01 |
| Normal-vs-Female |
9.358600E-01 |
| Male-vs-Female |
4.553600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.770100E-02 |
| Normal-vs-Extreme_Weight |
2.639600E-01 |
| Normal-vs-Obese |
3.930000E-01 |
| Normal-vs-Extreme_Obese |
9.960000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.316000E-01 |
| Normal_Weight-vs-Obese |
1.007410E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.448600E-01 |
| Extreme_Weight-vs-Obese |
1.700420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.167000E-01 |
| Obese-vs-Extreme_Obese |
1.249210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.593400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.047800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.560000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.096200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.540400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.332000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.681600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.554200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.155200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.354200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.229500E-02 |
| Normal-VS-Type2 PRCC |
3.348200E-01 |
| Normal-VS-KIRP CIMP |
3.002000E-01 |
| Normal-VS-Unclassified PRCC |
1.487540E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.110440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.549610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.840600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.248200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.214000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.218380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.510400E-01 |
| Normal-vs-N1 |
1.546390E-01 |
| Normal-vs-N2 |
1.538820E-03 |
| N0-vs-N1 |
1.399230E-01 |
| N0-vs-N2 |
6.158400E-02 |
| N1-vs-N2 |
4.384000E-03 |
|
|
